Image guided treatment optimalization with cetuximab for patients with metastatic colorectal cancer
Phase of Trial: Phase I/II
Latest Information Update: 23 Oct 2018
Price : $35 *
At a glance
- Drugs Cetuximab (Primary) ; Zirconium-89 cetuximab (Primary)
- Indications Adenocarcinoma; Colorectal cancer
- Focus Pharmacokinetics; Therapeutic Use
- Acronyms IMPACT-CRC
- 05 Oct 2018 Planned End Date changed from 1 Dec 2017 to 1 Mar 2019.
- 05 Oct 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Mar 2019.
- 31 Aug 2018 Biomarkers information updated